These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
23. The impact of treatment with levodopa on Parkinson's disease. Shaw KM; Lees AJ; Stern GM Q J Med; 1980; 49(195):283-93. PubMed ID: 7465763 [TBL] [Abstract][Full Text] [Related]
24. Dopa-responsive dystonia of childhood: a case report. Tan KK; Easaw PE Singapore Med J; 1995 Jun; 36(3):326-7. PubMed ID: 8553105 [TBL] [Abstract][Full Text] [Related]
25. Levodopa + carbidopa + entacapone. Entacapone: a second look: new preparations. Parkinson's disease: a modest effect. Prescrire Int; 2005 Apr; 14(76):51-4. PubMed ID: 15875340 [TBL] [Abstract][Full Text] [Related]
28. [Levodopa and controlled release benserazide in the handling of motor fluctuations in Parkinson's disease]. Díaz F; Chaná P Rev Med Chil; 1991 Sep; 119(9):1022-8. PubMed ID: 1845094 [TBL] [Abstract][Full Text] [Related]
29. A comparison of bromocriptine (Parlodel) and levodopa-carbidopa (Sinemet) for treatment of "de novo" Parkinson's disease patients. Libman I; Gawel MJ; Riopelle RJ; Bouchard S Can J Neurol Sci; 1987 Nov; 14(4):576-80. PubMed ID: 3319120 [TBL] [Abstract][Full Text] [Related]
30. Parkinson's disease: progression and mortality. Hoehn MM Adv Neurol; 1987; 45():457-61. PubMed ID: 3825726 [TBL] [Abstract][Full Text] [Related]
34. Pramipexole vs levodopa as initial treatment for Parkinson disease: a 4-year randomized controlled trial. Holloway RG; Shoulson I; Fahn S; Kieburtz K; Lang A; Marek K; McDermott M; Seibyl J; Weiner W; Musch B; Kamp C; Welsh M; Shinaman A; Pahwa R; Barclay L; Hubble J; LeWitt P; Miyasaki J; Suchowersky O; Stacy M; Russell DS; Ford B; Hammerstad J; Riley D; Standaert D; Wooten F; Factor S; Jankovic J; Atassi F; Kurlan R; Panisset M; Rajput A; Rodnitzky R; Shults C; Petsinger G; Waters C; Pfeiffer R; Biglan K; Borchert L; Montgomery A; Sutherland L; Weeks C; DeAngelis M; Sime E; Wood S; Pantella C; Harrigan M; Fussell B; Dillon S; Alexander-Brown B; Rainey P; Tennis M; Rost-Ruffner E; Brown D; Evans S; Berry D; Hall J; Shirley T; Dobson J; Fontaine D; Pfeiffer B; Brocht A; Bennett S; Daigneault S; Hodgeman K; O'Connell C; Ross T; Richard K; Watts A; Arch Neurol; 2004 Jul; 61(7):1044-53. PubMed ID: 15262734 [TBL] [Abstract][Full Text] [Related]
35. Comparison of standard carbidopa-levodopa and sustained-release carbidopa-levodopa in Parkinson's disease: pharmacokinetic and quality-of-life measures. Pahwa R; Lyons K; McGuire D; Silverstein P; Zwiebel F; Robischon M; Koller WC Mov Disord; 1997 Sep; 12(5):677-81. PubMed ID: 9380047 [TBL] [Abstract][Full Text] [Related]
36. A case of levodopa-responsive camptocormia associated with advanced Parkinson's disease. Ho B; Prakash R; Morgan JC; Sethi KD Nat Clin Pract Neurol; 2007 Sep; 3(9):526-30. PubMed ID: 17805247 [TBL] [Abstract][Full Text] [Related]
37. An analysis of treatment options and outcome in patients with Parkinson's disease and severe dyskinesias. Mark MH; Sage JI Ann Clin Lab Sci; 1994; 24(1):12-21. PubMed ID: 8147565 [TBL] [Abstract][Full Text] [Related]
38. Tyrosine hydroxylase deficiency causes progressive encephalopathy and dopa-nonresponsive dystonia. Hoffmann GF; Assmann B; Bräutigam C; Dionisi-Vici C; Häussler M; de Klerk JB; Naumann M; Steenbergen-Spanjers GC; Strassburg HM; Wevers RA Ann Neurol; 2003; 54 Suppl 6():S56-65. PubMed ID: 12891655 [TBL] [Abstract][Full Text] [Related]
39. Motor fluctuations during continuous levodopa infusions in patients with Parkinson's disease. Nutt JG; Carter JH; Lea ES; Woodward WR Mov Disord; 1997 May; 12(3):285-92. PubMed ID: 9159720 [TBL] [Abstract][Full Text] [Related]
40. [A form of dopa-responsive dystonia of late onset with diurnal fluctuations]. Maruta K; Okamoto S; Takegami T Rinsho Shinkeigaku; 1993 Mar; 33(3):341-3. PubMed ID: 8334800 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]